References
- Hundalani S G, Kulkarni M, Fernandes CJ, et al. Prostaglandin E1 for maintaining ductal patency in neonates with ductus-dependent cardiac lesions. Cochrane Database Syst Rev. 2014;Issue 12.Art. No.: CD011417.
- Lewis AB, Freed MD, Heymann MA, et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation. 1981;64:893–898.
- Mrvos R, Kerr FJ, Krenzelok EP, et al. Carboprost exposure in a newborn with recovery. J Toxicol Clin Toxicol. 1999;37:865–867.